163 related articles for article (PubMed ID: 29433346)
1. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages.
Vieira ACC; Chaves LL; Pinheiro M; Lima SAC; Ferreira D; Sarmento B; Reis S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):653-663. PubMed ID: 29433346
[TBL] [Abstract][Full Text] [Related]
2. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.
Vieira AC; Magalhães J; Rocha S; Cardoso MS; Santos SG; Borges M; Pinheiro M; Reis S
Nanomedicine (Lond); 2017 Dec; 12(24):2721-2736. PubMed ID: 29119867
[TBL] [Abstract][Full Text] [Related]
3. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
4. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S
Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137
[TBL] [Abstract][Full Text] [Related]
6. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages.
Vieira ACC; Chaves LL; Pinheiro M; Lima SC; Neto PJR; Ferreira D; Sarmento B; Reis S
Carbohydr Polym; 2021 Jan; 252():116978. PubMed ID: 33183580
[TBL] [Abstract][Full Text] [Related]
9. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
[TBL] [Abstract][Full Text] [Related]
10. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Chaubey P; Mishra B
Carbohydr Polym; 2014 Jan; 101():1101-8. PubMed ID: 24299880
[TBL] [Abstract][Full Text] [Related]
11. Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.
Maretti E; Costantino L; Buttini F; Rustichelli C; Leo E; Truzzi E; Iannuccelli V
Drug Deliv Transl Res; 2019 Feb; 9(1):298-310. PubMed ID: 30484257
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation.
Banerjee S; Roy S; Nath Bhaumik K; Kshetrapal P; Pillai J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):540-558. PubMed ID: 29373927
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Solid Lipid Nanoparticles of Sophorolipids Designed for Antileprosy Drugs.
Kanwar R; Gradzielski M; Mehta SK
J Phys Chem B; 2018 Jul; 122(26):6837-6845. PubMed ID: 29874078
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
16. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
18. Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus.
Ghaderkhani J; Yousefimashouf R; Arabestani M; Roshanaei G; Asl SS; Abbasalipourkabir R
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1181-1193. PubMed ID: 30942627
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria.
Mistry N; Bandyopadhyaya R; Mehra S
ACS Appl Bio Mater; 2022 Dec; 5(12):5779-5789. PubMed ID: 36441965
[TBL] [Abstract][Full Text] [Related]
20. Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis.
Prabhu P; Fernandes T; Chaubey P; Kaur P; Narayanan S; Vk R; Sawarkar SP
Drug Deliv Transl Res; 2021 Aug; 11(4):1509-1519. PubMed ID: 34021478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
